ExoRehab X

$49.00

99 in stock

ExoRehab X: Home Gym Tailored for Neuro-Recovery

  • Limited Availability: Only 300 custom-built devices will be available in 2022
  • 2022 Pre-orders end August 31
  • Shipments will be processed by September 15th and arrive within 6-8 weeks. Pre-orders will get priority in the delivery que.

ExoRehab X costs $3950. *Up to a 36-month financing option will be available for qualified individuals. The subscription for online training with other users, advanced personalization, and performance evaluation features is $29.99/month.

Pre-Order Details

  • Pre-order is limited to 100 devices
  • Deposit is fully refundable no questions asked
  • Get prioritized delivery
  • Enjoy $299 early-bird discount + free shipping and installation
  • Be part of shaping the future of neuro-recovery with your direct feedback to the R&D team

Complete Upper Extremity Training

Isolate and work on shoulder, elbow, forearm and wrist movements

Highly Ergonomic and Adjustable Structure

The chair and the exoskeleton are tailored for your body measurements and easy to adjust

Objective Performance Data

Onboard sensors capture every increment of improvement

Not Just an Exercise Equipment

A portal for connecting with fellow stroke survivors online

Gamified Training at the Comfort of Your Home

Training regimen that progressively pushes you forward

ExoRehab X tailors the training according to your movement capability and challenges you gradually based on your performance on every training session.

Witness Your Strength

Measure results in days, not months

Measure Your Performance

ExoRehab senses even the slightest improvement on your movement capability and keeps you motivated by reporting your progress daily using understandable metrics.

Move Forward Together

Train together with fellow stroke survivors online

You are not alone on your journey to recovery. With ExoRehab X, train with others online and push each other forward.

Clinically Proven Results

Chronic stage stroke survivors achieved on average 2.96 times higher improvement on the capability of carrying out activities of daily living compared to the control group which received conventional therapy (measured with Fugl-Meyer Assessment – FMA)